Hosted on MSN1mon
Baxter targets 5%-6% 2025 revenue growth amid Novum IQ pump success and operational recoveryBaxter International ended 2024 on a positive note, overcoming challenges posed by Hurricane Helene and delivering better-than-expected Q4 results. The success of the Novum IQ infusion pump ...
Hosted on MSN11mon
Baxter's (BAX) New Injectables Aid Its Pharmaceutical PortfolioBaxter recently received the FDA’s 510(k) clearance for its Novum IQ large volume infusion pump (LVP) with Dose IQ Safety Software. Adding LVP modality to the Novum IQ Infusion Platform ...
The US Food and Drug Administration (FDA) has issued an early alert over a ‘potentially high-risk’ issue with certain Baxter Sigma Spectrum and Spectrum IQ infusion pumps. The agency’s ...
For instance, in April 2024, Baxter International Inc. recently received FDA 510(k) clearance for its Novum IQ large volume infusion ... demand for next-generation IV pumps is expected to grow ...
The "North America and Europe Intravenous Infusion Pumps Market Size, Share & Trends Analysis Report by Product (Volumetric Infusion Pumps, Syringe Infusion Pumps), Disease Indication (Chemotherapy), ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results